Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

Background. Avian H5N1 influenza A virus is an emerging pathogen with the potential to cause substantial human morbidity and mortality. We evaluated the ability of currently licensed seasonal influenza vaccine to confer cross-protection against highly pathogenic H5N1 influenza virus in mice. Methods...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Infect Dis
Main Authors: Ichinohe, Takeshi, Tamura, Shin-ichi, Kawaguchi, Akira, Ninomiya, Ai, Imai, Masaki, Itamura, Shigeyuki, Odagiri, Takato, Tashiro, Masato, Takahashi, Hidehiro, Sawa, Hirofumi, Mitchell, William M., Strayer, David R., Carter, William A., Chiba, Joe, Kurata, Takeshi, Sata, Tetsutaro, Hasegawa, Hideki
פורמט: Artigo
שפה:Inglês
יצא לאור: The University of Chicago Press 2007
נושאים:
Major Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110255/
https://ncbi.nlm.nih.gov/pubmed/17922395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/521304
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים